HTFL
VENTE TOTALE: 98 028 titres (~4 078 423,82 $ US)
- Insiders
- Farquhar John C.M.
- Total bought
- —
- Total sold
- $4,078,424
- Last activity
- 2026-08-21
- Last synced
-
2026-08-27 10:00:12
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-06
HTFL presents a mixed profile: a strong earnings catalyst (48% revenue growth, raised guidance) is partially offset by deeply concerning fundamentals, including chronic negative profitability and negative operating cash…
The first sentence of the analysis written for HTFL on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Gross Profit Margin | 76.8% | 75.1% | 66.6% | |
| Ebit Margin | -57.8% | -58.5% | -80.8% | |
| Ebitda Margin | -52.9% | -52.0% | -72.1% | |
| Operating Profit Margin | -36.4% | -48.7% | -83.6% | |
| Pretax Profit Margin | -66.4% | -76.6% | -109.1% | |
| Continuous Operations Profit Margin | -66.3% | -76.6% | -109.7% | |
| Net Profit Margin | -66.3% | -76.6% | -109.7% | |
| Bottom Line Profit Margin | -66.3% | -76.6% | -141.9% | |
| Current Ratio | 5.197 | 2.449 | 4.524 | |
| Quick Ratio | 5.197 | 2.449 | 4.524 | |
| Solvency Ratio | -1.840 | -0.090 | -0.091 | |
| Cash Ratio | 1.057 | 1.529 | 3.741 | |
| Price To Earnings Ratio | -21.277 | -18.791 | -14.820 | |
| Price To Earnings Growth Ratio | 2.035 | 0.889 | 0.000 | |
| Forward Price To Earnings Growth Ratio | 2.035 | 0.889 | 0.000 | |
| Price To Earnings Diluted Ratio | -21.277 | -18.791 | -14.820 | |
| Price To Earnings Diluted Growth Ratio | 2.035 | 0.889 | 0.000 | |
| Price To Book Ratio | 8.269 | -2.109 | -2.361 | |
| Price To Sales Ratio | 14.122 | 14.411 | 21.062 | |
| Price To Free Cash Flow Ratio | -42.100 | -24.714 | -22.244 | |
| Price To Operating Cash Flow Ratio | -46.016 | -26.275 | -24.021 | |
| Debt To Assets Ratio | 0.061 | 1.351 | 0.868 | |
| Debt To Equity Ratio | 0.073 | -0.187 | -0.207 | |
| Debt To Capital Ratio | 0.068 | -0.229 | -0.260 | |
| Long Term Debt To Capital Ratio | 0.000 | -0.189 | -0.208 | |
| Financial Leverage Ratio | 1.196 | -0.138 | -0.238 | |
| Working Capital Turnover Ratio | 1.554 | 1.531 | 0.000 | |
| Operating Cash Flow Ratio | -1.275 | -2.053 | -2.329 | |
| Operating Cash Flow Sales Ratio | -0.307 | -0.548 | -0.877 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.093 | 1.063 | 1.080 | |
| Debt Service Coverage Ratio | -6.132 | -2.878 | -2.566 | |
| Interest Coverage Ratio | -4.222 | -2.689 | -2.953 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -2.450 | -0.430 | -0.476 | |
| Capital Expenditure Coverage Ratio | -10.751 | -15.837 | -12.520 | |
| Dividend Paid And Capex Coverage Ratio | -10.751 | -15.837 | -12.520 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -26.452 | -29.357 | -29.827 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 76.8% | ▲1.7% | ▲4.0% |
| Ebit Margin | -57.8% | ▲0.7% | ▲7.9% |
| Ebitda Margin | -52.9% | ▼-0.9% | ▲6.1% |
| Operating Profit Margin | -36.4% | ▲12.3% | ▲19.8% |
| Pretax Profit Margin | -66.4% | ▲10.2% | ▲17.6% |
| Continuous Operations Profit Margin | -66.3% | ▲10.3% | ▲17.9% |
| Net Profit Margin | -66.3% | ▲10.3% | ▲17.9% |
| Bottom Line Profit Margin | -66.3% | ▲10.3% | ▲28.6% |
| Current Ratio | 5.197 | ▲2.748 | ▲1.141 |
| Quick Ratio | 5.197 | ▲2.748 | ▲1.141 |
| Solvency Ratio | -1.840 | ▼-1.750 | ▼-1.166 |
| Cash Ratio | 1.057 | ▼-0.472 | ▼-1.052 |
| Price To Earnings Ratio | -21.277 | ▼-2.486 | ▼-2.981 |
| Price To Earnings Growth Ratio | 2.035 | ▲1.145 | ▲1.060 |
| Forward Price To Earnings Growth Ratio | 2.035 | ▲1.145 | ▲1.060 |
| Price To Earnings Diluted Ratio | -21.277 | ▼-2.486 | ▼-2.981 |
| Price To Earnings Diluted Growth Ratio | 2.035 | ▲1.145 | ▲1.060 |
| Price To Book Ratio | 8.269 | ▲10.378 | ▲7.003 |
| Price To Sales Ratio | 14.122 | ▼-0.289 | ▼-2.409 |
| Price To Free Cash Flow Ratio | -42.100 | ▼-17.386 | ▼-12.414 |
| Price To Operating Cash Flow Ratio | -46.016 | ▼-19.741 | ▼-13.912 |
| Debt To Assets Ratio | 0.061 | ▼-1.290 | ▼-0.699 |
| Debt To Equity Ratio | 0.073 | ▲0.260 | ▲0.180 |
| Debt To Capital Ratio | 0.068 | ▲0.298 | ▲0.209 |
| Long Term Debt To Capital Ratio | 0.000 | ▲0.189 | ▲0.132 |
| Financial Leverage Ratio | 1.196 | ▲1.334 | ▲0.922 |
| Working Capital Turnover Ratio | 1.554 | ▲0.023 | ▲0.526 |
| Operating Cash Flow Ratio | -1.275 | ▲0.778 | ▲0.611 |
| Operating Cash Flow Sales Ratio | -0.307 | ▲0.242 | ▲0.271 |
| Free Cash Flow Operating Cash Flow Ratio | 1.093 | ▲0.030 | ▲0.014 |
| Debt Service Coverage Ratio | -6.132 | ▼-3.254 | ▼-2.273 |
| Interest Coverage Ratio | -4.222 | ▼-1.533 | ▼-0.934 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | -2.450 | ▼-2.019 | ▼-1.331 |
| Capital Expenditure Coverage Ratio | -10.751 | ▲5.086 | ▲2.285 |
| Dividend Paid And Capex Coverage Ratio | -10.751 | ▲5.086 | ▲2.285 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -26.452 | ▲2.905 | ▲2.093 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Market cap | $2.49B | $1.81B | $1.84B | |
| Enterprise value | $2.46B | $1.92B | $1.87B | |
| EV / Sales | 13.99x | 15.28x | 21.50x | |
| EV / Op. cash flow | -45.60x | -27.86x | -24.52x | |
| EV / Free cash flow | -41.72x | -26.20x | -22.70x | |
| EV / EBITDA | -26.45x | -29.36x | -29.83x | |
| Net debt / EBITDA | 0.24x | -1.67x | -0.60x | |
| Current ratio | 5.20x | 2.45x | 4.52x | |
| Income quality | 0.46x | 0.72x | 0.80x | |
| Graham net-net | $2 | -$14 | -$13 | |
| Tax burden | 99.9% | 100.1% | 100.6% | |
| Interest burden | 114.9% | 130.9% | 135.1% | |
| Working capital | $177.8M | $48.7M | $115.6M | |
| Invested capital | $203.9M | $76.4M | $146.5M | |
| Return on assets | -32.5% | -81.2% | -51.7% | |
| Operating ROA | -26.8% | -40.3% | 0.0% | |
| Return on tangible assets | -32.5% | -86.9% | -54.0% | |
| Return on equity | -38.8% | 11.2% | 12.3% | |
| Return on invested capital | -19.8% | -67.6% | -46.3% | |
| Return on capital employed | -20.2% | -71.9% | -47.9% | |
| Earnings yield | -4.7% | -5.3% | -5.2% | |
| Free cash flow yield | -2.4% | -4.0% | -4.5% | |
| Capex / Op. cash flow | -9.3% | -6.3% | -8.0% | |
| Capex / Depreciation | 58.6% | 53.6% | 80.4% | |
| Capex / Sales | 2.9% | 3.5% | 7.0% | |
| SG&A / Sales | 76.3% | 89.1% | 109.1% | |
| R&D / Sales | 36.9% | 34.6% | 41.1% | |
| Stock comp / Sales | 7.9% | 8.1% | 13.6% | |
| Intangibles / Total assets | 0.0% | 6.5% | 4.3% | |
| Days sales outstanding | 61d | 79d | 94d | |
| Days payables outstanding | 28d | 33d | 36d | |
| Operating cycle | 61d | 79d | 94d | |
| Cash conversion cycle | 33d | 45d | 58d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-20 HeartFlow''s Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors? The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The transaction reduced the insider''s direct equity position by 10%, while total beneficial ownership decreased by 4%.
- 2026-08-16 HeartFlow: An Impressive MedTech Growth Play HeartFlow delivered a convincing Q2 with 48% sales growth and gross margins rising to 83%, driving strong market optimism. The company raised full-year revenue guidance to $246–$250 million, though the outlook appears conservative given recent momentum and sequential growth. Shares now trade at 13x sales, supported by accelerating topline growth, expanding plaque-related revenue, and commercial adoption of its non-invasive cardiac solution.
- 2026-08-14 Why Heartflow Stock Soared Today Heartflow''s AI-powered platform could save countless lives. The company is growing at an impressive clip.
- 2026-08-14 HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance HeartFlow Inc. (NASDAQ:HTFL) shares are trading sharply higher Friday afternoon after the company reported better-than-expected second-quarter adjusted EPS results and raised its full-year financial outlook.
- 2026-08-14 HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript
- 2026-08-13 Heartflow Q2 Earnings Call Highlights Heartflow NASDAQ: HTFL reported second-quarter revenue of $64.1 million, up 48% from a year earlier, as growth in its Plaque Analysis offering, durable FFR-CT utilization and continued expansion of the coronary CT angiography, or CCTA, market supported results.
- 2026-08-13 HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates HeartFlow (HTFL) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $1.46 per share a year ago.
- 2026-08-13 Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results for the second quarter ended June 30, 2026.
- 2026-07-31 Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More After a week of wild swings that rattled portfolios and left investors guessing, Wall Street analysts are already reshuffling their ratings on Friday morning, with some surprising cuts and upgrades across sectors from utilities to gaming that could reshape how you think about your positions.
- 2026-07-15 What Does the HeartFlow CEO''s Sale of Over 20,000 Company Shares Mean for Investors? The medical technology company reported a notable insider sale in recent filings.